Est. 2001·3,000+ placements · six offices · four regions

Company signals · Biotech & Pharma

Valion Bio

1 signal in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: The wider read — a Talent Market Index of 95.4 (Cool), down 5.3 month-on-month — shows Americas signal flow easing (-16.2pts).

Valion Bio: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 31 tracked companies.

Signals at Valion Bio

Executive hires, departures and board changes at Valion Bio

Every leadership-change and senior-hiring signal observed at Valion Bio, newest first, each dated and linked to the source record.

Valion Bio signals in the last 90 days

1 public signal observed since 22 August 2026, by type.

More signals across Biotech & Pharma

Leadership Change · Americas

Vir Biotechnology →

Vir Biotechnology (Nasdaq: VIR) appointed Johns Hopkins cancer immunotherapy expert Suzanne Topalian, M.D., to its Board of Directors, effective October 27, 2026.

Leadership Change · Americas

Valion Bio Inc. →

Valion Bio names Thomas H. Jensen, CEO of Allarity Therapeutics, as board chair to advance Entolimod program for acute radiation syndrome following company transformation

Leadership Change · Americas

Flagship Pioneering →

Flagship Pioneering, a scientific innovation engine, appointed two Executive Partners: Fidah Alsagoff (Head of Global Initiatives) and Maggie Sahlman (Head of Fundraising and Investor Relations).

Leadership Change · Americas

Teva Pharmaceuticals →

Teva Pharmaceuticals CEO Richard Francis discusses Q2 earnings, drug pipeline, and the company's direct listing on NYSE. Signals leadership visibility and capital market transition.

Product Launch · Americas

ABEC →

ABEC announced the commercial launch of the ATB-2100 Advanced Therapy Bioreactor, a single-use cell expansion platform aimed at advanced therapy (cell and gene therapy) manufacturing.

Partnership · Americas

Boehringer Ingelheim →

Endpoints News teaser references a collaboration between Boehringer Ingelheim and Microsoft. The excerpt is truncated and gives no terms, scope or deal size.

Where Valion Bio's market lands in our work

Weekly briefing

Track companies like Valion Bio — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

MitchelLake is a global executive search and advisory firm covering AI, innovation and expansion leadership for companies navigating transformation and change across industries, from startups and scale-ups to private-equity-backed and enterprise organisations. 3,000+ C-suite, specialist and board placements since 2001.

Data period
23 Sept 2026 – 23 Sept 2026 · 1 signals for this company
Publisher
MitchelLake

Last updated